» Articles » PMID: 31868565

The Randomized Trials of 10% Urea Cream and 0.025% Tretinoin Cream in the Treatment of Acanthosis Nigricans

Overview
Publisher Informa Healthcare
Specialty Dermatology
Date 2019 Dec 24
PMID 31868565
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acanthosis nigricans is characterized as hyperpigmented skin and velvety surface on posterior and lateral folds of the neck and the intertriginous areas. This study aimed to assess the efficacy of topical 10% urea cream compared to 0.025% tretinoin cream in the treatment of acanthosis nigricans.

Material And Methods: This was an 8-week trial, double-blind, randomized, comparative study of topical 10% urea and 0.025% tretinoin for the treatment of the neck hyperpigmentation. The Mexameter MX18 was used for assessing treatment efficacy. The global evaluation scale was also used to evaluate the overall success rate at weeks 2, 4, and 8 of the study.

Results: There was a statistically significant difference between 10% urea and 0.025% tretinoin in the treatment of acanthosis nigricans ( < 0.01). The efficacy of 10% urea and 0.025% tretinoin treatment shows 11.4 ± 5.7% and 20.1 ± 9.7% improvement, respectively. The treatment efficacy using the investigator's global evaluation found that 36.8% of participants treated with 10% urea and 63.2% of participants treated with 0.025% tretinoin had more than 75% skin improvement.

Conclusion: Both medications significantly improved neck hyperpigmentation. However, the efficacy of 0.025% tretinoin was significantly better than 10% urea in the treatment of acanthosis nigricans.

Clinical Trials Registry: TCTR20180703003.

Citing Articles

Assessing the efficacy and safety profiles of 0.025% tretinoin in treating axillary hyperpigmentation with acanthosis nigricans: a randomized double-blinded study.

Chunekamrai P, Chatpimolkul N, Thummawatwimon S, Treesirichod A Arch Dermatol Res. 2025; 317(1):297.

PMID: 39833642 DOI: 10.1007/s00403-025-03821-y.


Global hotspots and trends in Acanthosis nigricans research: A bibliometric and visualized analysis.

Zhang S, Yan H, Sun W, Li J, Xu J, Cao D Skin Res Technol. 2024; 30(9):e70054.

PMID: 39258800 PMC: 11388607. DOI: 10.1111/srt.70054.


Gender, racial, ethnic, and Fitzpatrick skin type representation in Acanthosis nigricans clinical trials.

Wang J, Bitterman D, Patel P, Kabakova M, Zafar K, Cohen M Arch Dermatol Res. 2024; 316(6):332.

PMID: 38842735 DOI: 10.1007/s00403-024-02996-0.


Efficacy of 15% trichloroacetic acid peel versus 35% glycolic acid peel in acanthosis Nigricans: A randomized open-label study.

Bharati B, Sarkar R, Garg T, Goyal R, Mendiratta V J Cutan Aesthet Surg. 2024; 17(2):94-99.

PMID: 38800813 PMC: 11126224. DOI: 10.4103/JCAS.JCAS_76_23.


Correlation between Acanthosis Nigricans Scoring Chart (ANSC) and narrowband reflectance spectrophotometer in assessing severity of acanthosis nigricans.

Treesirichod A, Kritsanaviparkporn C, Sangaphunchai P, Chansakulporn S Skin Res Technol. 2023; 29(8):e13428.

PMID: 37632186 PMC: 10387586. DOI: 10.1111/srt.13428.